Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Proteomics01:33

Proteomics

7.9K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Developmental status and prospect of musical electroacupuncture].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2015
Same author

Utility of Tc-PEG4-E[PEG4-c(RGDfK)]2 in Posttherapy Surveillance of Patients with Reelevated Carcinoembryonic Antigen Levels.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre·2015
Same author

Characterization of the impurities and isomers in cefetamet pivoxil hydrochloride by liquid chromatography/time-of-flight mass spectrometry and ion trap mass spectrometry.

Journal of pharmaceutical and biomedical analysis·2015
Same author

(68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.

Bioconjugate chemistry·2015
Same author

An exploratory study on 99mTc-RGD-BBN peptide scintimammography in the assessment of breast malignant lesions compared to 99mTc-3P4-RGD2.

PloS one·2015
Same author

Chemoradiation therapy reduces aldehyde dehydrogenase 1 expression in cervical cancer but does not improve patient survival.

Medical oncology (Northwood, London, England)·2015

相关实验视频

Updated: Sep 10, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

781

在解读前列腺癌的瘤微环境和治疗耐药性机制时整合多组蛋白质组方法

Yutao Wang1, Fan Wang2, Qi Pan3

  • 1Department of Urology, The First Hospital of China Medical University, Shenyang 110001, China; Department of Urology, Chinese Academy of Medical Sciences, Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100005, China.

Biochimica et biophysica acta. Reviews on cancer
|August 22, 2025
PubMed
概括

这篇综述强调了多组蛋白质组方法如何解开前列腺癌瘤微环境和耐药性的复杂性. 了解这些相互作用是开发新疗法和改善患者治疗结果的关键.

关键词:
多种类型前列腺癌蛋白质组学治疗耐药性瘤微环境

更多相关视频

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.2K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K

相关实验视频

Last Updated: Sep 10, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

781
Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.2K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K

科学领域:

  • 癌症学
  • 蛋白质组学
  • 基因组学

背景情况:

  • 前列腺癌 (PCa) 仍然是癌症死亡的主要原因,瘤微环境 (TME) 和耐药性构成了主要的治疗障碍.
  • 由于复杂的TME和耐药机制的发展,有效的PCa治疗受到挑战.

研究的目的:

  • 审查多组蛋白质组方法的整合,以了解PCa TME和药物耐药性.
  • 探索如何将蛋白质组学与基因组学,转录组学和代谢组学结合起来可以阐明癌症的进展和治疗失败.

主要方法:

  • 在前列腺癌中综合蛋白质组学,基因组学,转录组学和代谢组学的多组学研究.
  • 分析TME特征的蛋白质分析技术,包括细胞外基质和免疫成分.
  • 检查单细胞蛋白质组以了解瘤异质性.

主要成果:

  • 多组学方法提高了对PCa进展,免疫规避和治疗失败的分子驱动因素的理解.
  • TME的蛋白质分析揭示了细胞外基质和免疫调节剂等关键组成部分.
  • 单细胞蛋白质组学提供了关于瘤异质性和抵抗机制的见解.
  • 多组学识别了转化后的修改和激酶通路导致治疗耐药性.

结论:

  • 对于解读PCa TME复杂性和抵抗机制而言,多组蛋白质组策略至关重要.
  • 这些方法具有显著的生物标志物发现和PCa个性化药物的发展潜力.
  • 整合多种药物对于改善前列腺癌患者的临床结果至关重要.